Clinical trials for stem cell transplantation: when are they needed?

In recent years, both stem cell research and the clinical application of these promising cells have increased rapidly. About 1000 clinical trials using stem cells have to date been performed globally. More importantly, more than 10 stem cell-based products have been approved in some countries. With...

Descripción completa

Detalles Bibliográficos
Autor principal: Van Pham, Phuc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848855/
https://www.ncbi.nlm.nih.gov/pubmed/27121227
http://dx.doi.org/10.1186/s13287-016-0325-0
_version_ 1782429433335906304
author Van Pham, Phuc
author_facet Van Pham, Phuc
author_sort Van Pham, Phuc
collection PubMed
description In recent years, both stem cell research and the clinical application of these promising cells have increased rapidly. About 1000 clinical trials using stem cells have to date been performed globally. More importantly, more than 10 stem cell-based products have been approved in some countries. With the rapid growth of stem cell applications, some countries have used clinical trials as a tool to diminish the rate of clinical stem cell applications. However, the point at which stem cell clinical trials are essential remains unclear. This commentary discusses when stem cell clinical trials are essential for stem cell transplantation therapies.
format Online
Article
Text
id pubmed-4848855
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48488552016-04-29 Clinical trials for stem cell transplantation: when are they needed? Van Pham, Phuc Stem Cell Res Ther Commentary In recent years, both stem cell research and the clinical application of these promising cells have increased rapidly. About 1000 clinical trials using stem cells have to date been performed globally. More importantly, more than 10 stem cell-based products have been approved in some countries. With the rapid growth of stem cell applications, some countries have used clinical trials as a tool to diminish the rate of clinical stem cell applications. However, the point at which stem cell clinical trials are essential remains unclear. This commentary discusses when stem cell clinical trials are essential for stem cell transplantation therapies. BioMed Central 2016-04-27 /pmc/articles/PMC4848855/ /pubmed/27121227 http://dx.doi.org/10.1186/s13287-016-0325-0 Text en © Van Pham. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Van Pham, Phuc
Clinical trials for stem cell transplantation: when are they needed?
title Clinical trials for stem cell transplantation: when are they needed?
title_full Clinical trials for stem cell transplantation: when are they needed?
title_fullStr Clinical trials for stem cell transplantation: when are they needed?
title_full_unstemmed Clinical trials for stem cell transplantation: when are they needed?
title_short Clinical trials for stem cell transplantation: when are they needed?
title_sort clinical trials for stem cell transplantation: when are they needed?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848855/
https://www.ncbi.nlm.nih.gov/pubmed/27121227
http://dx.doi.org/10.1186/s13287-016-0325-0
work_keys_str_mv AT vanphamphuc clinicaltrialsforstemcelltransplantationwhenaretheyneeded

Ejemplares similares